Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Larson

Showing results (1021-1030 of 1,352) with videos related to

Pageof 136
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1989
Reduction of background activities by introduction of a diester linkage between antibody and a chelate in radioimmunodetection of tumorC H Paik, K Yokoyama, J C Reynolds, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapyNeeta Pandit-Taskar, Joseph A O'Donoghue, Michael J Morris, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 12, 2006
[131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicityPat Zanzonico, Guenther Koehne, Humilidad F Gallardo, et al.
Pigment Cell Research|May 23, 2007
Informatic and genomic analysis of melanocyte cDNA libraries as a resource for the study of melanocyte development and functionLaura L Baxter, Benjamin J Hsu, Lowell Umayam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2003
Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRIStig Palm, Richard M Enmon, Cornelia Matei, et al.
The American Journal of Gastroenterology|June 28, 2018
Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish CausalityDaniel R Ganger, Jody Rule, Jorge Rakela, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatosesS M Larson, J A Carrasquillo, D C Colcher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2013
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancerMary L Gemignani, Sujata Patil, Venkatraman E Seshan, et al.
JACC. Cardiovascular Interventions|September 20, 2014
Outcomes of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with previous coronary bypass surgeryLouis P Kohl, Ross F Garberich, Hannah Yang, et al.
Pageof 136

Showing results (1021-1030 of 1,352) with videos related to

Sort By:
Pageof 136
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1989
Reduction of background activities by introduction of a diester linkage between antibody and a chelate in radioimmunodetection of tumorC H Paik, K Yokoyama, J C Reynolds, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapyNeeta Pandit-Taskar, Joseph A O'Donoghue, Michael J Morris, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 12, 2006
[131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicityPat Zanzonico, Guenther Koehne, Humilidad F Gallardo, et al.
Pigment Cell Research|May 23, 2007
Informatic and genomic analysis of melanocyte cDNA libraries as a resource for the study of melanocyte development and functionLaura L Baxter, Benjamin J Hsu, Lowell Umayam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2003
Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRIStig Palm, Richard M Enmon, Cornelia Matei, et al.
The American Journal of Gastroenterology|June 28, 2018
Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish CausalityDaniel R Ganger, Jody Rule, Jorge Rakela, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatosesS M Larson, J A Carrasquillo, D C Colcher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2013
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancerMary L Gemignani, Sujata Patil, Venkatraman E Seshan, et al.
JACC. Cardiovascular Interventions|September 20, 2014
Outcomes of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with previous coronary bypass surgeryLouis P Kohl, Ross F Garberich, Hannah Yang, et al.
Pageof 136